Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease

Transfusion Medicine

Volumn 6, Issue 3, 1996, Pages 261-271

  Chapman, J ^a   Finney, R D ^a   Forman, K ^a,a   Kelsey, P ^a   Knowles, S M ^a   Napier, J A F ^a   Phillips, P ^a   Mitchell, R ^a   Murphy, M F ^a   Waters, A H ^a   Wood, J K ^a   Williamson, L M ^a   Baglin, T ^a   Copplestone, A ^a   Dendy, P ^a   Gibson, B ^a   Knowles, S ^a   Morgan, G ^a   Norfolk, D ^a   Richards, A ^a   Todd, A ^a   Warwick, R ^a   Webb, D ^a   Cavill, I ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030239925     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3148.1996.tb00078.x     Document Type: Review

References (14)

1. Anderson, K.C., Goodnough, LT., Sayers M. et al. (1991) Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-vs.-host disease. Blood, 77, 2096-2102.
2. Cheson, B.D. (1995) Infectious and immunosuppressive complications of purine analog therapy. Journal of Clinical Oncology, 13, 2431-2448.
3. Commission of the European Communities. (1992) EC Guide to Good Manufacturing Practice, Vol. I. V. Annex 12, Use of Ionising Radiation in the Manufacture of Medicinal Products. HMSO.
4. FDA. (1993) Recommendations Regarding License Amendments and Procedures for Gamma Irradiation of Blood Products. Food and Drug Administration.
5. Leitman, S.F. (1993) Dose, dosimetry and quality improvement of irradiated blood components. Transfusion, 33, 447.
6. Masterson, M.E. & Febo, R. (1992) Pretransfusion blood irradiation: clinical rationale and dosemetric consideration. Medical Physics, 19, 649-657.
7. McMilin, K.D. & Johnson, R.L. (1993) HLA homozygosity and the risk of related-donor transfusion associated graft-vs.-host disease. Transfusion Medicine Reviews, 7, 37-41.
8. NBTS/NIBSC. (1993) Guidelines for the Transfusion Service. HMSO.
9. Parkman, R., Mosier, D., Umansky, I., et al. (1974) Graft-vs.-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. New England Journal of Medicine, 290, 359-363.
10. Sanders, M.R. & Graeber, J.E. (1990) Posttransfusion graft-vs.-host disease in infancy. Journal of Pediatrics, 117, 159-163.
11. Sazama, K. & Holland, P.V. (1993) Transfusion-induced graft-vs.-host disease. In: Immunobiology of Transfusion Medicine (ed. Garratty, G.), Marcel Dekker, New York.
12. Spitzer, T.R., Cahill, R., Cottler-Fox, M., et al. (1990) Transfusion induced graft vs. host disease in patients with malignant lymphoma. Cancer, 66, 2346-2349.
13. Strauss, R.G. (1990) Routinely washing irradiated red cells before transfusion seems unwarranted. Transfusion, 30, 675-677.
14. The Royal College of Physicians of Edinburgh. (1993) Consensus Conference: Leucocyte Depletion of Blood and Blood Components.